| ISIN | LU1660425858 |
|---|---|
| Valor Number | 37774579 |
| Bloomberg Global ID | |
| Fund Name | DNB Fund-Health Care C1 (ACC) EUR |
| Fund Provider |
DNB Asset Management AS
Stockholm, Sweden Phone: +46 8 473 41 00 Web: www.cim.se |
| Fund Provider | DNB Asset Management AS |
| Representative in Switzerland |
FundPartner Solutions (Suisse) SA Genève 75 |
| Distributor(s) |
Allfunds International Schweiz AG
DZ Private Bank (schweiz) AG
Fund Channel (Suisse) SA Nyon 2 Phone: +4122 0000 Swissquote Bank Gland Phone: +41 22 999 94 11 UBS AG Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | Emphasis is placed on investments in the equities of companies operating in or associated with the health care sectors. Geographically the Sub-Fund has full flexibility. The Sub-Fund may invest between 5% and 15% of its net assets in equities quoted on the Hong Kong Stock exchange or on the Shanghai Stock exchange. |
| Peculiarities |
| Current Price * | 105.66 EUR | 26.11.2025 |
|---|---|---|
| Previous Price * | 105.44 EUR | 25.11.2025 |
| 52 Week High * | 105.66 EUR | 26.11.2025 |
| 52 Week Low * | 101.61 EUR | 19.11.2025 |
| NAV * | 105.66 EUR | 26.11.2025 |
| Issue Price * | 105.66 EUR | 26.11.2025 |
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 103,757,474 | |
| Unit/Share Assets *** | 103,598,724 | |
| Trading Information SIX | ||
| YTD Performance | - | - |
|---|---|---|
| YTD Performance (in CHF) | - | - |
| 1 month | +3.98% |
19.11.2025 - 26.11.2025
19.11.2025 26.11.2025 |
| 3 months | - | - |
| 6 months | - | - |
| 1 year | - | - |
| 2 years | - | - |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 7.09% | |
|---|---|---|
| Johnson & Johnson | 6.15% | |
| AstraZeneca PLC | 5.99% | |
| Roche Holding AG | 5.92% | |
| Novo Nordisk AS Class B | 5.07% | |
| UnitedHealth Group Inc | 4.64% | |
| DexCom Inc | 3.43% | |
| Sanofi SA | 3.32% | |
| Thermo Fisher Scientific Inc | 3.28% | |
| Lonza Group Ltd | 3.27% | |
| Last data update | 30.09.2025 | |
| TER *** | 0.86% |
|---|---|
| TER date *** | 31.08.2025 |
| Performance Fee *** | 10.00% |
| PTR | |
| Max. Management Fee *** | 0.75% |
| Ongoing Charges *** | 0.78% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |